Characterization of Spherulites as a Lipidic Carrier for Low and High Molecular Weight Agents
To develop spherulite formulations to achieve high entrapment efficiency for both small and macromolecules as well as cell-type specific delivery.
Spherulites of various compositions were prepared, and lipid-PEG was incorporated through post-insertion. Calcein and FITC-labeled albumin were employed as model drugs for small and macromolecules. The spherulites were characterized with respect to entrapment efficiency, size, structure, and release kinetics, and the morphology was examined via cryo-EM. Finally, SV119-decorated spherulites were examined for their selective uptake by cancer cells.
The spherulites are 170 ~ 290 nm in size. A loading efficiency of 55 ~ 60% can be consistently achieved for both calcein and albumin under optimized conditions. Cryo-EM shows the onion-like morphology consistent with the structure of multilamellar liposomes. A t1/2 of 39.3 h and 69.7 h in cargo release in serum was observed before and after PEG decoration, and incorporation of SV119 led to selective delivery of rhodamine-labeled spherulites to PC-3 tumor cells.
Our optimized formulations may represent a platform with simple preparation approach, relatively small particle size, high drug loading efficiency for both low and high molecular weight agents, and slow release kinetics for selective delivery of various types of therapeutics to target cells.
KEY WORDScryo-electron microscopy entrapment efficiency multilamellar liposomes spherulites targeted drug delivery
bovine serum albumin
dynamic light scattering
Dulbecco’s modified eagle’s medium
Dulbecco’s phosphate buffered saline
enhanced permeability and retention
fetal bovine serum
fluorescein isothiocyanate-labeled succinylated bovine serum album
polyoxyethylene 80 sorbitan monooleate
Acknowledgments and Disclosures
This work was supported in part by NIH grants R01HL091828, R21CA128415 and R21CA155983.
- 5.Forrest ML, Yáñez JA, Remsberg CM, Ohgami Y, Kwon GS, Davies NM. Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(e-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity. Pharm Res. 2008;25(1):194–206.PubMedCrossRefGoogle Scholar